Amyotrofic Lateral Sclerosis (ALS) research hub

A Phase 1b/2 Study to Evaluate NB-4746 in Participants with Amyotrophic Lateral Sclerosis.

This study is looking at a new medicine called NB-4746 for people with Motor Neurone Disease (ALS). It aims to see if it's safe, what side effects it might have, and if it helps with the condition. It's an early-stage study.